Glancy Binkow & Goldberg LLP Announces Class Action
Court Watch
Notice is hereby given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for the Southern District of New York on behalf of all purchasers of the American Depositary Shares of China Medical Technologies, Inc. between November 26, 2007 and December 12, 2011, inclusive seeking to pursue remedies under the Securities Exchange Act of 1934.
A copy of the Complaint is available from the court or from Glancy Binkow & Goldberg LLP. Please contact us by phone to discuss this action or to obtain a copy of the Complaint at (310) 201-9150 or Toll Free at (888) 773-9224, by email at shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com.
China Medical develops, manufactures and markets immunodiagnostic and molecular diagnostic products. The Complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose material adverse facts about the Company's business, operations and prospects, including: (1) that the Company’s acquisition of Beijing Bio-Ekon Biotechnology Co. Ltd. (“BBE”) was from a third-party seller connected to China Medical’s CEO; (2) that the Company substantially overpaid to acquire BBE; (3) that China Medical’s acquisition of BBE involved the use of fraudulent shell companies; (4) that the Company was suffering substantial operating losses prior to the acquisition; (5) that a majority of the Company’s accounts receivable were in excess of 120 days; (6) that, as a result, China Medical’s financial results were overstated; (7) that the Company lacked adequate internal and financial controls; and (8), as a result of the foregoing, that the Company's statements were materially false and misleading at all relevant times.
Plaintiff seeks to recover damages on behalf of class members and is represented by Glancy Binkow & Goldberg LLP, a law firm with significant experience in prosecuting class actions and substantial expertise in actions involving corporate fraud.
http://www.glancylaw.com
Related listings
-
Trump vows to change how elections are run. Constitution doesn’t grant that power
Court Watch 08/19/2025President Donald Trump on Monday vowed more changes to the way elections are conducted in the U.S., but based on the Constitution there is little to nothing he can do on his own.Relying on false information and conspiracy theories that he’s reg...
-
Victims feeling exhausted and anxious about wrangling over Epstein files
Court Watch 08/05/2025Women who say they were abused by Jeffrey Epstein are feeling skeptical and anxious about the Justice Department’s handling of records related to the convicted sex offender, with some backing more public disclosures as an overdue measure of tra...
-
San Francisco to ban homeless people from living in RVs with new parking limit
Court Watch 07/22/2025San Francisco is set to ban homeless people from living in RVs by adopting strict new parking limits the mayor says are necessary to keep sidewalks clear and prevent trash buildup. The policy, up for final approval by San Francisco supervisors Tuesda...